is one of India’s leading BI-monthly
Pharma journals, appropriately referred
to as the Umbrella Journal of the Pharma
Industry. With its high quality of
content, it is abstracted and Indexed by
the International Pharmaceutical
Abstracts & Chemical Abstracts-USA,
Index Copernicus-Poland and is listed in
Ulrich Database-USA. The journal
provides an excellent platform for
authors, researchers and advertisers.
Also available in user friendly flip
book digital format online and on CD
Rom, the journal has readership in many
countries, provides media support to
Pharma Expos and Conferences worldwide
and has a large number of advertisers
from India and overseas.
Communicating Genetic Disease Risk
has Little or No Impact on Health
Robert Scoffin, CEO of Cresset,
awarded Fellowship of Royal Society
Welcome Report Calling for Radical
Reform of The Medical Council of
Cancer Drug Development Shifting
from Small Molecules to Monoclonal
Antibodies, says GBI Research
Ground breaking Ceremony Heralds the
Creation of a New 70 Million Euro
Indonesian Pharma: Merck Sees
Healthy Growth Ahead
Biopsy' Using Blood Test is Latest
Weapon Against Cancer
Soon to Fix Heart Attack Tear?
Test Spots Tumors Earlier Than CT
comes to an end and with that we
complete 13 years of uninterrupted
publication of 'The Pharma Review'.
2015 has been a mixed bag for the
country which was high on expectations
after last year's general election.
Review regularly conducts interviews of
a cross section of industry
personalities. To read more, click here.
noteworthy is the journal's contribution
to the globalization of the Indian
Pharma Industry. Wishing great success
to The Pharma Review.